Personalis, Inc.

Personalis, Inc. (PSNL) Stock Overview

Explore Personalis, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PSNLNASDAQ
HealthcareMedical - Diagnostics & Research
$14.54
$0.49(3.26%)
U.S. Market is Open · 15:35

Personalis, Inc. (PSNL)

Meyka AI Score

Z

Key Financials

Market Cap1.4B
P/E Ratio-15.30
EPS (TTM)$-1.02
ROE-0.44%
Fundamental Analysis

AI Price Forecasts

1 Month$13.32
3 Months$12.11
1 Year Target$11.81

PSNL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Personalis, Inc. (PSNL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 75.05, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $11.81.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -15.30 and a market capitalization of 1.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
5.06%
5-Day Change
7.93%
1-Month Change
61.29%
3-Month Change
138.16%
6-Month Change
64.31%
Year-to-Date (YTD) Change
98.37%
1-Year Change
150.24%
3-Year Change
621.005%
5-Year Change
-24.81%
All-Time (Max) Change
-44.58%

Contact Information

650 752 1300
1330 O’Brien Drive, Fremont, CA, 94025

Company Facts

2,280 Employees
IPO DateJun 20, 2019
CountryUS
Actively Trading

Frequently Asked Questions